The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer - Top-Institutions - MDSpire

The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer

  • By

  • Frederik R. Teunissen

  • Thomas Willigenburg

  • Richard P. Meijer

  • Harm H. E. van Melick

  • Helena M. Verkooijen

  • Jochem R. N. van der Voort van Zyp

  • July 21, 2022

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    University Medical Center Utrecht
    University Medical Center Utrecht

    Utrecht, Netherlands

    Key Differentiators

    • Urologic Oncology
    • Radiation Oncology
    • Clinical Epidemiology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urologic Oncology
    • Radiation Oncology
    • Clinical Trials

  • #3

    Dana-Farber Cancer Institute / Brigham and Women's Hospital
    Dana-Farber Cancer Institute / Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Urologic Oncology
    • Radiation Oncology
    • Clinical Epidemiology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Urologic Oncology
    • Radiation Oncology
    • Clinical Trials

  • #5

    The Royal Marsden NHS Foundation Trust
    The Royal Marsden NHS Foundation Trust

    London, England

    Key Differentiators

    • Urologic Oncology
    • Radiation Oncology
    • Clinical Trials

Original Source(s)

The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer

  • by Frederik R. Teunissen, Thomas Willigenburg, Richard P. Meijer, Harm H. E. van Melick, Helena M. Verkooijen, Jochem R. N. van der Voort van Zyp

  • July 21, 2022

Related Content

Radiotherapy in metastatic bladder cancer

Analysis of High-Dose-Rate Brachytherapy Outcomes in Prostate Cancer Patients Aged 75 and Older

Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer